NDC 0002-1210

TAUVID

Flortaucipir F-18

TAUVID is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Eli Lilly And Company. The primary component is Flortaucipir F-18.

• Product ID: 0002-1210_0e4e3839-33b1-4f14-a2e8-0b137f0a9e6d
• NDC: 0002-1210
• Product Type: Human Prescription Drug
• Proprietary Name: TAUVID
• Generic Name: Flortaucipir F-18
• Dosage Form: Injection, Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2020-05-28
• Marketing Category: NDA / NDA
• Application Number: NDA212123
• Labeler Name: Eli Lilly and Company
• Substance Name: FLORTAUCIPIR F-18
• Active Ingredient Strength: 51 mCi/mL
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 0002-1210-30

1 VIAL, MULTI-DOSE in 1 CAN (0002-1210-30) > 30 mL in 1 VIAL, MULTI-DOSE

• Marketing Start Date: 2020-05-28
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0002-1210-50 [00002121050]

TAUVID INJECTION, SOLUTION

• Marketing Category: NDA
• Application Number: NDA212123
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2020-05-28

NDC 0002-1210-30 [00002121030]

TAUVID INJECTION, SOLUTION

• Marketing Category: NDA
• Application Number: NDA212123
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2020-05-28

Drug Details

NDC Crossover Matching brand name "TAUVID" or generic name "Flortaucipir F-18"

NDC	Brand Name	Generic Name
0002-1210	TAUVID	Flortaucipir F-18
0002-1220	TAUVID	Flortaucipir F-18